Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A01068 | 34881283 | Front Nutr | Caffeine and EGCG Alleviate High-Trans Fatty Acid and High-Carbohydrate Diet-Induced NASH in Mice: Commonality and Specificity. | 2021 | Details |
| A01069 | 34880774 | Front Physiol | Effect of Long-Term Exercise on Liver Lipid Metabolism in Chinese Patients With NAFLD: A Systematic Review and Meta-Analysis. | 2021 | Details |
| A01071 | 34879108 | PLoS One | PNPLA3 downregulation exacerbates the fibrotic response in human hepatic stellate cells. | 2021 | Details |
| A01072 | 34878523 | Endocrinology | Adipose-specific VDR Deletion Leads to Hepatic Steatosis in Female Mice Fed a Low-Fat Diet. | 2022 | Details |
| A01073 | 34878418 | Curr Opin Anaesthesiol | Preoperative evaluation of geriatric patients undergoing liver transplantation. | 2022 | Details |
| A01074 | 34877910 | Expert Rev Gastroenterol Hepatol | Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2021 | Details |
| A01075 | 34877270 | World J Clin Cases | Pharmaconutrition strategy to resolve SARS-CoV-2-induced inflammatory cytokine storm in non-alcoholic fatty liver disease: Omega-3 long-chain polyunsaturated fatty acids. | 2021 | Details |
| A01076 | 34876392 | Turk J Gastroenterol | Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study. | 2021 | Details |
| A01077 | 34876018 | BMC Gastroenterol | Variations in TM6SF2, PCSK9 and PCSK7 genes and risk of hepatic steatosis after liver transplantation: a cross-sectional study. | 2021 | Details |
| A01078 | 34875824 | J Prev Med Public Health | Association Between Low Muscle Mass and Non-alcoholic Fatty Liver Disease Diagnosed Using Ultrasonography, Magnetic Resonance Imaging Derived Proton Density Fat Fraction, and Comprehensive NAFLD Score in Korea. | 2021 | Details |
| A01079 | 34875531 | Public Health | NFI, a clinical scoring tool for predicting non-alcoholic fatty liver in the Chinese population. | 2021 | Details |
| A01081 | 34875127 | J Intern Med | Adherence to a vegetable dietary pattern attenuates the risk of non-alcoholic fatty liver disease in incident type 2 diabetes: The TCLSIH cohort study. | 2021 | Details |
| A01082 | 34874519 | Chin J Integr Med | Lycium barbarum Polysaccharides Promotes Mitochondrial Biogenesis and Energy Balance in a NAFLD Cell Model. | 2021 | Details |
| A01083 | 34873855 | Clin Obes | Risk and protective factors of non-alcoholic fatty liver disease in paediatric obesity: A nationwide nested case-control study. | 2021 | Details |
| A01084 | 34873633 | Eur Radiol Exp | Advances in liver US, CT, and MRI: moving toward the future. | 2021 | Details |
| A01085 | 34873092 | AIDS | A pilot study of microbial signatures of liver disease in those with HIV mono-infection in Rio de Janeiro, Brazil. | 2022 | Details |
| A01086 | 34872787 | Ultrasound Med Biol | Superb Microvascular Imaging-Based Vascular Index to Assess Adult Hepatic Steatosis: A Feasibility Study. | 2021 | Details |
| A01087 | 34872379 | Am J Mens Health | A Qualitative Analysis of Mexican-Origin Men's Knowledge and Cultural Attitudes Toward Non-Alcoholic Fatty Liver Disease and Interest in Risk Reduction. | 2022 | Details |
| A01088 | 34872045 | Clin Nutr | Τhe anthropometric and biochemical profile of pediatric non-alcoholic fatty liver disease: A systematic review and a meta-analysis. | 2021 | Details |
| A01089 | 34871813 | Clin Gastroenterol Hepatol | An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD. | 2021 | Details |
| A01090 | 34871812 | Clin Gastroenterol Hepatol | Intensive Lifestyle Management Improves Steatosis and Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01091 | 34871361 | Arch Pathol Lab Med | Pathologic Diagnosis of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01092 | 34871234 | Medicine (Baltimore) | Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndrome. | 2021 | Details |
| A01093 | 34871105 | Crit Rev Food Sci Nutr | Phytosterols as bioactive food components against nonalcoholic fatty liver disease. | 2021 | Details |
| A01094 | 34870783 | J Gastrointest Cancer | The Gut Microbiome and Hepatocellular Carcinoma. | 2021 | Details |
| A01095 | 34870551 | Pharm Biol | Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK. | 2022 | Details |
| A01096 | 34870139 | Metabol Open | Protective effects of cerium oxide nanoparticles in non-alcoholic fatty liver disease (NAFLD) and carbon tetrachloride-induced liver damage in rats: Study on intestine and liver. | 2021 | Details |
| A01097 | 34870138 | Metabol Open | Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD). | 2021 | Details |
| A01098 | 34869957 | JACC Basic Transl Sci | Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction. | 2021 | Details |
| A01099 | 34869587 | Front Mol Biosci | Therapeutic Targeting of Nonalcoholic Fatty Liver Disease by Downregulating SREBP-1C Expression via AMPK-KLF10 Axis. | 2021 | Details |
| A01100 | 34869532 | Front Nutr | Clinical Relevance of Vitamins and Carotenoids With Liver Steatosis and Fibrosis Detected by Transient Elastography in Adults. | 2021 | Details |
| A01101 | 34869521 | Front Nutr | Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A01104 | 34869352 | Front Cell Dev Biol | Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma. | 2021 | Details |
| A01105 | 34868307 | Gastroenterol Res Pract | Is the Occurrence or Reversal of Nonalcoholic Fatty Liver Disease Associated with Long-Term Helicobacter pylori Infection among Chinese Adults? A Cohort Study. | 2021 | Details |
| A01106 | 34867414 | Front Pharmacol | The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A01107 | 34867384 | Front Pharmacol | Effects of Nigella sativa, Camellia sinensis, and Allium sativum as Food Additives on Metabolic Disorders, a Literature Review. | 2021 | Details |
| A01108 | 34867358 | Front Pharmacol | (+)-Dehydrovomifoliol Alleviates Oleic Acid-Induced Lipid Accumulation in HepG2 Cells via the PPARα-FGF21 Pathway. | 2021 | Details |
| A01109 | 34867343 | Front Pharmacol | Polygoni Multiflori Radix Praeparata Ethanol Extract Exerts a Protective Effect Against High-Fat Diet Induced Non-Alcoholic Fatty Liver Disease in Mice by Remodeling Intestinal Microbial Structure and Maintaining Metabolic Homeostasis of Bile Acids. | 2021 | Details |
| A01110 | 34866939 | Cancer Manag Res | Metabolic Syndrome-Related Hyperuricemia is Associated with a Poorer Prognosis in Patients with Colorectal Cancer: A Multicenter Retrospective Study. | 2021 | Details |
| A01111 | 34866849 | J Clin Exp Hepatol | Tobacco, Cigarettes, and the Liver: The Smoking Gun. | 2021 | Details |
| A01112 | 34866847 | J Clin Exp Hepatol | Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting-A Retrospective Descriptive Analysis. | 2021 | Details |
| A01113 | 34866843 | J Clin Exp Hepatol | Role of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis and Grading of Hepatic Steatosis in Patients With Non-alcoholic Fatty Liver Disease: Comparison With Ultrasonography and Magnetic Resonance Spectroscopy. | 2021 | Details |
| A01114 | 34866842 | J Clin Exp Hepatol | Adipocytokines as Risk Factors for Development of Nonalcoholic Fatty Liver Disease in Children. | 2021 | Details |
| A01115 | 34866201 | Aliment Pharmacol Ther | A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach. | 2021 | Details |
| A01116 | 34865353 | Zhonghua Gan Zang Bing Za Zhi | [Study on the state of macrophage infiltration in the progression of non-alcoholic fatty liver disease induced by high-fat diet in mice]. | 2020 | Details |
| A01117 | 34864598 | Int J Hyg Environ Health | Exposure to polycyclic aromatic hydrocarbons and volatile organic compounds is associated with a risk of obesity and diabetes mellitus among Korean adults: Korean National Environmental Health Survey (KoNEHS) 2015-2017. | 2021 | Details |
| A01118 | 34863942 | Mol Metab | The metabolic syndrome, thiazolidinediones, and implications for intersection of chronic and inflammatory disease. | 2021 | Details |
| A01119 | 34863940 | Mol Metab | URAT1-selective inhibition ameliorates insulin resistance by attenuating diet-induced hepatic steatosis and brown adipose tissue whitening in mice. | 2021 | Details |
| A01121 | 34863034 | J Hepatobiliary Pancreat Sci | Incidence and risk factors of nonalcoholic fatty liver disease after total pancreatectomy: A first multicenter prospective study in Japan. | 2021 | Details |
| A01124 | 34862975 | FASEB J | Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling. | 2022 | Details |
| A01125 | 34862599 | Br J Pharmacol | Amlodipine, an anti-hypertensive drug, alleviates non-alcoholic fatty liver disease by modulating gut microbiota. | 2022 | Details |
| A01126 | 34862596 | Br J Pharmacol | Ruthenium 360 and mitoxantrone inhibit mitochondrial calcium uniporter channel to prevent liver steatosis induced by high-fat diet. | 2022 | Details |
| A01127 | 34862475 | Commun Biol | Hepatoprotective effects of Cassiae Semen on mice with non-alcoholic fatty liver disease based on gut microbiota. | 2021 | Details |
| A01128 | 34861841 | BMC Gastroenterol | FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran. | 2021 | Details |
| A01129 | 34861339 | Prev Med | Physical activity and diet quality in relation to non-alcoholic fatty liver disease: A cross-sectional study in a representative sample of U.S. adults using NHANES 2017-2018. | 2021 | Details |
| A01130 | 34861229 | Environ Res | CRISPR screen identified that UGT1A9 was required for bisphenols-induced mitochondria dyshomeostasis. | 2021 | Details |
| A01131 | 34860705 | Eur J Gastroenterol Hepatol | Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial. | 2022 | Details |
| A01132 | 34860704 | Eur J Gastroenterol Hepatol | Serum copper, ceruloplasmin, and their relations to metabolic factors in nonalcoholic fatty liver disease: a cross-sectional study. | 2022 | Details |
| A01133 | 34860208 | J Occup Environ Med | Determination of Cardiovascular Risk in 56,262 Spanish Construction Workers: Cardiovascular Risk in Construction Workers. | 2021 | Details |
| A01134 | 34859513 | Phytother Res | Scutellarin ameliorates hepatic lipid accumulation by enhancing autophagy and suppressing IRE1α/XBP1 pathway. | 2021 | Details |
| A01135 | 34859497 | J Gastroenterol Hepatol | Low serum pancreatic amylase levels as a novel latent risk factor for colorectal adenoma in non-alcohol drinkers. | 2021 | Details |
| A01136 | 34859106 | J Immunol Res | Hyperlipidemia May Synergize with Hypomethylation in Establishing Trained Immunity and Promoting Inflammation in NASH and NAFLD. | 2021 | Details |
| A01137 | 34858740 | Cureus | Pioglitazone for the Treatment of Metabolic-Associated Fatty Liver Disease in People Living With HIV and Prediabetes. | 2021 | Details |
| A01138 | 34858322 | Front Endocrinol (Lausanne) | The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review. | 2021 | Details |
| A01139 | 34857248 | Clin Nutr ESPEN | Effect of l-carnitine supplementation on liver fat content and cardiometabolic indices in overweight/obese women with polycystic ovary syndrome: A randomized controlled trial. | 2021 | Details |
| A01140 | 34857244 | Clin Nutr ESPEN | High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus. | 2021 | Details |
| A01141 | 34857059 | J Dev Orig Health Dis | Maternal high-fat diet consumption programs male offspring to mitigate complications in liver regeneration. | 2021 | Details |
| A01142 | 34856978 | BMC Pulm Med | Novel screening model of obstructive sleep apnea for snorers with suspected NAFLD undergoing liver sonography. | 2021 | Details |
| A01143 | 34856895 | Curr Protein Pept Sci | Soybean β-Conglycinin: Structure Characteristic, Allergenicity, Plasma Lipid-Controlling, Prevention of Obesity and Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A01144 | 34856688 | Zhonghua Nei Ke Za Zhi | [Correlation between intrahepatic triglyceride content quantified by proton magnetic resonance spectroscopy and glucose metabolism]. | 2021 | Details |
| A01145 | 34855819 | PLoS One | Association of small intestinal bacterial overgrowth with nonalcoholic fatty liver disease in children: A meta-analysis. | 2021 | Details |
| A01146 | 34855640 | Chin Med J (Engl) | Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma. | 2021 | Details |
| A01147 | 34855339 | FP Essent | Liver Disease: Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01148 | 34854929 | Eur Radiol | Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease. | 2021 | Details |
| A01149 | 34854066 | Hormones (Athens) | Nonalcoholic fatty liver disease: lifestyle and quality of life. | 2021 | Details |
| A01150 | 34853966 | Bull Exp Biol Med | Knockdown of Sirt1 Gene in Mice Results in Lipid Accumulation in the Liver Mediated via PGC-1α-Induced Mitochondrial Dysfunction and Oxidative Stress. | 2021 | Details |
| A01151 | 34853949 | Handb Exp Pharmacol | Inter-Organ Crosstalk in the Development of Obesity-Associated Insulin Resistance. | 2021 | Details |
| A01152 | 34853313 | Nat Commun | GP73 is a TBC-domain Rab GTPase-activating protein contributing to the pathogenesis of non-alcoholic fatty liver disease without obesity. | 2021 | Details |
| A01153 | 34851748 | Can J Physiol Pharmacol | The anti-anginal ranolazine does not confer beneficial actions against hepatic steatosis in male mice subjected to high-fat diet and streptozotocin-induced type 2 diabetes. | 2021 | Details |
| A01154 | 34850865 | Dis Model Mech | Concerted regulation of non-alcoholic fatty liver disease progression by microRNAs in apolipoprotein E-deficient mice. | 2021 | Details |
| A01155 | 34850615 | Clin Chem Lab Med | Afamin predicts the prevalence and incidence of nonalcoholic fatty liver disease. | 2021 | Details |
| A01156 | 34850445 | J Gastroenterol Hepatol | The microbial metabolome in metabolic-associated fatty liver disease. | 2021 | Details |
| A01157 | 34849373 | Front Phys | Feasibility of Hepatic Fat Quantification Using Proton Density Fat Fraction by Multi-Echo Chemical-Shift-Encoded MRI at 7T. | 2021 | Details |
| A01158 | 34849196 | Comput Struct Biotechnol J | Gut microbiome signatures distinguish type 2 diabetes mellitus from non-alcoholic fatty liver disease. | 2021 | Details |
| A01159 | 34848984 | Diabetes Metab Syndr Obes | Effect of LncPVT1/miR-20a-5p on Lipid Metabolism and Insulin Resistance in NAFLD. | 2021 | Details |
| A01160 | 34848839 | Exp Mol Med | Roles of IκB kinases and TANK-binding kinase 1 in hepatic lipid metabolism and nonalcoholic fatty liver disease. | 2021 | Details |
| A01161 | 34848360 | J Ethnopharmacol | Crocetin ameliorates non-alcoholic fatty liver disease by modulating mitochondrial dysfunction in L02 cells and zebrafish model. | 2021 | Details |
| A01162 | 34848359 | J Ethnopharmacol | Systematic characterization of the metabolites of defatted walnut powder extract in vivo and screening of the mechanisms against NAFLD by UPLC-Q-Exactive Orbitrap MS combined with network pharmacology. | 2021 | Details |
| A01164 | 34847883 | BMC Gastroenterol | Total polyunsaturated fatty acid intake and the risk of non-alcoholic fatty liver disease in Chinese Han adults: a secondary analysis based on a case-control study. | 2021 | Details |
| A01167 | 34847213 | Food Funct | Curcumin supplementation improves biomarkers of oxidative stress and inflammation in conditions of obesity, type 2 diabetes and NAFLD: updating the status of clinical evidence. | 2021 | Details |
| A01168 | 34847156 | PLoS One | Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE). | 2021 | Details |
| A01169 | 34845832 | Liver Int | Binge drinking induces an acute burst of markers of hepatic fibrogenesis (PRO-C3). | 2021 | Details |
| A01170 | 34843158 | Liver Int | Causal effects from non-alcoholic fatty liver disease on kidney function: A Mendelian randomization study. | 2021 | Details |
| A01171 | 34842411 | Anal Chem | Highly Selective Fluorescent Probe Design for Visualizing Hepatic Hydrogen Sulfide in the Pathological Progression of Nonalcoholic Fatty Liver. | 2021 | Details |
| A01172 | 34841632 | Hepatol Res | Comparison of diagnostic performance between FIB-4 and NFS in metabolic-associated fatty liver disease era. | 2021 | Details |
| A01173 | 34841290 | Cell Rep Med | Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease. | 2021 | Details |
| A01174 | 34840719 | Ther Adv Endocrinol Metab | NAFLD in type 1 diabetes: overrated or underappreciated? | 2021 | Details |
| A01175 | 34840484 | J Clin Exp Hepatol | The Outcome after Hospital Discharge in Cirrhosis is Not Worsened with COVID-19 Infection: A Propensity Score-matched Analysis. | 2021 | Details |
| A01176 | 34840086 | J Diabetes Complications | First-degree family history of diabetes is associated with nonalcoholic fatty liver disease independent of glucose metabolic status. | 2021 | Details |
| A01177 | 34839623 | Clin Mol Hepatol | Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients. | 2021 | Details |